$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
How often should rubitin/rubicatin (Zanbega) be administered and instructions for treatment schedule
2026-02-01 22:25:32
Check Details
What indicators need to be reviewed regularly during the use of Platinib (Pujihua)?
2026-02-01 22:25:32
Check Details
Sharing the causes and improvement methods of loss of appetite caused by capmatinib (Touradida)
2026-02-01 22:25:32
Check Details
Recommendations for the management of abnormal liver function during treatment with sotoraxib (AMG 510)
2026-02-01 22:25:32
Check Details
Suggestions on how to purchase generic adagrasib (Krazati) drugs and select regular channels
2026-02-01 22:25:32
Check Details
Analysis of the chemical synthesis route and R&D background of Pimitespib
2026-02-01 22:25:32
Check Details
Afatinib medical insurance indications and reimbursement policy explanation
2026-02-01 22:25:32
Check Details
Daridorexant Hydrochloride Tablets Approved Marketing Information and Precautions
2026-02-01 22:25:32
Check Details
Analysis of the reasons why some patients are not recommended to take Lynparza
2026-02-01 22:25:32
Check Details
Comprehensive analysis and reference of the efficacy and side effects of venetoclax/venetoclax (venetoclax)
2026-02-01 22:25:32
Check Details
Detailed explanation of the indications and treatment scope of Asnib/Assiminib
2026-02-01 22:25:32
Check Details
Common side effects and safe medication precautions of ritixitinib (Lefenox)
2026-02-01 22:25:32
Check Details
1
2
...
2140
2141
2142
2143
2144
2145
2146
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma